Multicentric evaluation of in utero dexamethasone (DEX) on the cognitive development of children at risk of Congenital Adrenal Hyperplasia - PRENATAL DEX Study - PRENATAL DEX

Hospices Civils de Lyon0 个研究点开始时间: 2015年12月4日最近更新: 2016年1月18日

适应症

试验速览

暂无简介。

•Male or female
•- Patient with Congenital Adrenal Hyperplasia or sibling of a CAH patient
•- Age: 6 to 15 years (at the time of inclusion)
•- The subject's legal representatives have understood the information note/informed consent form, obtained answers to all their questions and have given signed, written, informed consent
•- Subject with health insurance
•For Schoolchildren:
•- Male or female
•- With no connection with Congenital Adrenal Hyperplasia
•- Age: 6 to 15 years (at the time of inclusion)
•- The subject's legal representatives have understood the information note/informed consent form, obtained answers to all their questions and have given signed, written, informed consent
•- Subject with health insurance
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 400
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•- Patient/Subject with another genetic disease
•- Patient/Subject with known neuropsychology disease(s)
•- Patient/Subject whose mother has received another treatment during her pregnancy with possible known adverse events on the neuropsychological development of the child

发起方